Zika Virus: Epidemiology, Virology, and Counter Measures

Video

At IDWeek 2016, Mark Mulligan, MD, Hope Clinic at Emory Vaccine Center discussed his team's recent projects studying the natural history of Zika infection and their Zika vaccine trial.

At IDWeek 2016, Mark Mulligan, MD, Hope Clinic at Emory Vaccine Center discussed his team's recent projects studying the natural history of Zika infection and their Zika vaccine trial. In their study of US travelers (residents of Atlanta) who went to Zika - affected areas and became ill, Mulligan and team look at the levels of virus in various body fluids and also study their immune responses. Mulligan said that the point of studying Zika's history is to get fundamental information to better design and develop counter measures that are vaccines, treatments, and diagnostic tests. He explained the primary need is to develop vaccines for women and pregnant women, and that it's also important to start thinking of Zika as a sexually transmitted infection.

Recent Videos
How to Address Blistering Diseases, with Donna Culton, MD, PhD
Matthew Zirwas, MD: Discussing Upadacitinib, Other JAK Inhibitors for Atopic Dermatitis
Differentiating Between Different Types of Alopecia, with Jerry Shapiro, MD
Julie Harper, MD: Discussing Acne Treatment Updates, Unmet Needs Among Patients
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD
Review of Recent Advancements in Dermatology, with Matthew Zirwas, MD
Allison Moser, MSN, RN, FNP-BC | Credit: Allison Moser on LinkedIn
Raj Chovatiya, MD, PhD: Treating Hidradenitis Suppurativa with IL-17, JAK Inhibitors
Most Promising New Drugs for Hidradenitis Suppurativa, with Raj Chovatiya, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.